Key Events This Week
27 Jul: Stock opens week at ₹572.60, up 2.09%
28 Jul: Paushak upgraded to Hold by MarketsMOJO; stock closes at ₹582.00 (+1.64%)
29 Jul: Technical momentum shifts to mildly bullish; stock dips slightly to ₹581.50 (-0.09%)
30 Jul: Strong quarterly results announced; stock surges 3.88% to ₹604.05
31 Jul: Continued gains on positive financial trend; closes at ₹629.55 (+4.22%)
Are Paushak Ltd latest results good or bad?
2026-07-31 19:20:28Paushak Ltd's latest financial results for Q1 FY27 reveal a complex operational landscape characterized by significant revenue growth but notable margin compression. The company reported a net sales figure of ₹83.55 crores, reflecting a robust quarter-on-quarter growth of 51.52% and a year-on-year increase of 49.52%. This surge in revenue indicates strong demand for its specialty chemicals, particularly isocyanates, chloroformates, and carbamates. However, despite this impressive top-line performance, profitability metrics have shown a decline. The net profit for the quarter was ₹15.10 crores, which represents a quarter-on-quarter increase of 25.49% but a year-on-year decrease of 20.70%. This divergence highlights challenges in maintaining profitability amid rising input costs and operational inefficiencies, as evidenced by the profit after tax (PAT) margin dropping to 18.07%, down from 21.53% in the previ...
Read full news article
Paushak Ltd Reports Strong Quarterly Financial Turnaround Amid Specialty Chemicals Sector Challenges
2026-07-31 08:00:26Paushak Ltd, a micro-cap player in the specialty chemicals sector, has demonstrated a marked improvement in its financial performance for the quarter ended June 2026. The company’s financial trend has shifted from flat to positive, driven by record quarterly sales and profit metrics, signalling a potential turnaround after a period of subdued growth.
Read full news article
Paushak Q1 FY27: Stellar Revenue Surge Masks Margin Pressure and Valuation Concerns
2026-07-30 22:17:02Paushak Limited, India's largest phosgene-based specialty chemicals manufacturer and a legacy entity within the Alembic Group, delivered a mixed performance in Q1 FY27, posting net profit of ₹15.10 crores—a robust 25.49% quarter-on-quarter increase but a 20.70% year-on-year decline. The company's shares surged 3.88% to ₹604.05 on July 30, 2026, reflecting investor optimism around a 51.52% sequential revenue jump to ₹83.55 crores, the highest quarterly sales figure on record.
Read full news article
Paushak Ltd Upgraded to Hold by MarketsMOJO Amid Mixed Financial and Technical Signals
2026-07-29 08:24:56Paushak Ltd, a micro-cap player in the specialty chemicals sector, has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced shift in its technical outlook despite ongoing financial challenges. The upgrade, effective from 28 July 2026, is driven primarily by improvements in technical indicators, while valuation and financial trends remain subdued, signalling cautious optimism among investors.
Read full news article
Paushak Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook
2026-07-29 08:03:26Paushak Ltd, a micro-cap player in the specialty chemicals sector, has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Recent technical indicators, including MACD, Bollinger Bands, and moving averages, reveal a nuanced picture of the stock’s price dynamics, suggesting cautious optimism among investors amid mixed signals across weekly and monthly timeframes.
Read full news article
Paushak Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-07-24 08:02:58Paushak Ltd, a micro-cap player in the specialty chemicals sector, has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a modest day decline of 0.36%, the stock’s technical indicators present a complex picture, with weekly signals showing bullish tendencies contrasting with monthly bearishness. This article delves into the detailed technical parameters, price momentum, and comparative returns to provide a comprehensive analysis for investors.
Read full news article







